Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer
March 04, 2024 08:00 ET
|
Osmol Therapeutics
Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer